+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopharmaceutical CMO & CRO Market by Service Type (Analytical, Cell Culture, Clinical Development), Product Type (Large Molecule, Small Molecule), Application, End User - Global Forecast 2025-2030- Product Image
Biopharmaceutical CMO & CRO Market by Service Type (Analytical, Cell Culture, Clinical Development), Product Type (Large Molecule, Small Molecule), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Biopharmaceutical CMO & CRO Market by Service Type (Analytical, Cell Culture, Clinical Development), Product Type (Large Molecule, Small Molecule), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 186 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010880
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The biopharmaceutical contract manufacturing and research outsourcing market is evolving, as organizations increasingly seek specialized partners to keep pace with advancing therapies, regulatory frameworks, and geopolitical pressures. Senior executives must navigate a complex ecosystem of service segments, technology innovation, supply chain shifts, and regional strategies to inform robust outsourcing decisions.

Market Snapshot: Biopharmaceutical CMO & CRO Market Growth

The Biopharmaceutical CMO & CRO Market grew from USD 95.65 billion in 2024 to USD 113.74 billion in 2025. It is expected to continue expanding at a compound annual growth rate (CAGR) of 18.22%, reaching USD 261.14 billion by 2030. Surging demand for complex biologics, gene therapies, and innovative vaccine platforms is accelerating outsourcing needs across contract manufacturing and research services. Competitive differentiation is now increasingly tied to technology adoption, process efficiency, and the ability to address regional market requirements.

Scope & Segmentation

  • Service Types: Analytical, cell culture, clinical development (Phase I, II, III), fill-finish, formulation, preclinical development, process development.
  • Product Types: Large molecule (including biologics, biosimilars), small molecule (generics, new chemical entities).
  • Applications: Cell therapies (CAR T, stem cell), gene therapies (non viral, viral vector), monoclonal antibodies (bispecific, conjugated, naked), recombinant proteins (enzymes, growth factors, hormones), vaccines (inactivated, live attenuated, mRNA, subunit).
  • End Users: Biotechnology companies (large and small biotech), contract research organizations (full and niche service), pharmaceutical companies (Tier I, II, III), research institutions (academia, government).
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Saudi Arabia, South Africa), Asia-Pacific (China, India, Japan, Australia, Singapore, among others).
  • Technologies: Cell culture, process development platforms, high-throughput analytics, digital supply chain solutions, modular manufacturing, regulatory intelligence systems.

Key Takeaways for Senior Decision-Makers

  • Scientific advances in cell and gene therapy are driving increased demand for partners with deep technical expertise and integrated manufacturing capabilities.
  • Regulatory harmonization, particularly adaptive licensing, is prompting investment in compliance processes and regional regulatory intelligence.
  • Digital transformation—including analytics, automation, and modular facility designs—enables scalable, quality-focused solutions that reduce development risk and timelines.
  • Strategic partnerships and joint ventures are crucial to securing capacity for new modalities, especially as the industry moves toward long-term, end-to-end collaboration models.
  • Regional market maturity, such as North American hub specialization or Asia-Pacific’s scale in development and manufacturing, should inform outsourcing choices.
  • Segmented service offerings aligned to specific modality, product type, and end-user needs create differentiation in a highly competitive field.

Tariff Impact: Navigating 2025 U.S. Changes

New United States tariffs introduced in 2025 created significant economic and supply chain challenges. Increased import duties on critical materials and equipment have driven providers to adjust procurement, diversify supplier bases, and consider expanding onshore manufacturing. These shifts impact project timelines, capital expenditure, and the attractiveness of regional hubs—particularly prompting companies to evaluate partnerships within tariff-exempt or cost-efficient locations for sustained operational advantage.

Methodology & Data Sources

This research integrates primary interviews with senior leaders from biotechnology, pharmaceutical, contract development and manufacturing, and regulatory organizations. Proprietary databases, regulatory reviews, and expert validation workshops form the backbone of trend analysis and strategic insights, ensuring all perspectives are representative and data-driven.

Why This Report Matters

  • Enables executives to benchmark current outsourcing strategies against industry direction, regional advantages, and emerging operational models.
  • Offers clarity on navigating tariff and regulatory disruptions, including practical recommendations for aligning sourcing and risk mitigation initiatives.
  • Supports data-driven decisions by mapping the interplay between technology innovation, evolving service offerings, and regional infrastructure developments.

Conclusion

The biopharmaceutical CMO & CRO market is at an inflection point. Informed, agile outsourcing decisions—grounded in strategic alignment, risk mitigation, and technology adoption—are essential for capturing growth and ensuring quality as the landscape evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Strategic partnerships between small molecule CMOs and lipid nanoparticle technology providers to enhance mRNA vaccine manufacturing capacity
5.2. Adoption of continuous bioprocessing platforms by contract manufacturers to accelerate monoclonal antibody production timelines
5.3. Integration of artificial intelligence-driven process analytical technology in CRO services for real-time biopharmaceutical quality monitoring
5.4. Expansion of single-use bioreactor systems by CMOs to support flexible and scalable pandemic response manufacturing capabilities
5.5. Emergence of decentralized clinical trial supply models facilitated by CROs to optimize cold chain logistics and patient engagement
5.6. Implementation of modular plug and play production units by contract manufacturers for rapid-response biologics scale-up
5.7. Growing demand for gene therapy manufacturing services driving capacity investments in viral vector production at CMOs
5.8. Utilization of digital twin simulations by biopharmaceutical CMOs to optimize upstream process development and reduce time to clinic
5.9. Rise of specialized CROs offering integrated pharmacovigilance and real-world evidence analytics for post-marketing biotherapeutics
5.10. Development of end-to-end RNA drug development platforms by integrated CMO-CRO partnerships to streamline regulatory submissions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopharmaceutical CMO & CRO Market, by Service Type
8.1. Introduction
8.2. Analytical
8.3. Cell Culture
8.4. Clinical Development
8.4.1. Phase I
8.4.2. Phase II
8.4.3. Phase III
8.5. Fill-Finish
8.6. Formulation
8.7. Preclinical Development
8.8. Process Development
9. Biopharmaceutical CMO & CRO Market, by Product Type
9.1. Introduction
9.2. Large Molecule
9.2.1. Biologics
9.2.1.1. Monoclonal Antibodies
9.2.1.2. Recombinant Proteins
9.2.1.3. Vaccines
9.2.2. Biosimilars
9.3. Small Molecule
9.3.1. Generics
9.3.2. New Chemical Entities
10. Biopharmaceutical CMO & CRO Market, by Application
10.1. Introduction
10.2. Cell Therapies
10.2.1. CAR T
10.2.2. Stem Cell
10.3. Gene Therapies
10.3.1. Non Viral
10.3.2. Viral Vector
10.4. Monoclonal Antibodies
10.4.1. Bispecific
10.4.2. Conjugated
10.4.3. Naked
10.5. Recombinant Proteins
10.5.1. Enzymes
10.5.2. Growth Factors
10.5.3. Hormones
10.6. Vaccines
10.6.1. Inactivated
10.6.2. Live Attenuated
10.6.3. mRNA
10.6.4. Subunit
11. Biopharmaceutical CMO & CRO Market, by End User
11.1. Introduction
11.2. Biotechnology Companies
11.2.1. Large Biotech
11.2.2. Small Biotech
11.3. CROs
11.3.1. Full Service
11.3.2. Niche Service
11.4. Pharmaceutical Companies
11.4.1. Tier I
11.4.2. Tier II
11.4.3. Tier III
11.5. Research Institutions
11.5.1. Academia
11.5.2. Government
12. Americas Biopharmaceutical CMO & CRO Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biopharmaceutical CMO & CRO Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biopharmaceutical CMO & CRO Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. IQVIA Services Inc.
15.3.2. Laboratory Corporation of America Holdings
15.3.3. Lonza Group AG
15.3.4. Syneos Health, Inc.
15.3.5. Charles River Laboratories International, Inc.
15.3.6. ICON plc
15.3.7. Catalent, Inc.
15.3.8. Parexel International Corporation
15.3.9. WuXi Biologics Co., Ltd.
15.3.10. Samsung Biologics Co., Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICAL CMO & CRO MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOPHARMACEUTICAL CMO & CRO MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOPHARMACEUTICAL CMO & CRO MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIOPHARMACEUTICAL CMO & CRO MARKET: RESEARCHAI
FIGURE 24. BIOPHARMACEUTICAL CMO & CRO MARKET: RESEARCHSTATISTICS
FIGURE 25. BIOPHARMACEUTICAL CMO & CRO MARKET: RESEARCHCONTACTS
FIGURE 26. BIOPHARMACEUTICAL CMO & CRO MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOPHARMACEUTICAL CMO & CRO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ANALYTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ANALYTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FILL-FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOSIMILARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENERICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENERICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NEW CHEMICAL ENTITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NEW CHEMICAL ENTITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CAR T, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CAR T, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STEM CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STEM CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NON VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NON VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BISPECIFIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BISPECIFIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CONJUGATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CONJUGATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NAKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NAKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FULL SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FULL SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NICHE SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NICHE SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER I, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER I, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER II, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER II, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER III, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER III, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ACADEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ACADEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GOVERNMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 217. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 218. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 219. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 220. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 221. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2024 (USD MILLION)
TABLE 224. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2025-2030 (USD MILLION)
TABLE 225. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 226. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 227. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2024 (USD MILLION)
TABLE 228. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2025-2030 (USD MILLION)
TABLE 229. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 232. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 233. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 234. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 235. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 236. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 237. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 238. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 239. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 240. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 241. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 244. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 245. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 246. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 247. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 248. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 249. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 250. CANADA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 251. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 252. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 255. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2024 (USD MILLION)
TABLE 258. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2025-2030 (USD MILLION)
TABLE 259. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2024 (USD MILLION)
TABLE 262. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 266. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 267. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 268. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 269. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 270. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 271. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 272. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 273. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 274. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 275. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2024 (USD MILLION)
TABLE 278. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2025-2030 (USD MILLION)
TABLE 279. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2024 (USD MILLION)
TABLE 280. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2025-2030 (USD MILLION)
TABLE 281. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2024 (USD MILLION)
TABLE 282. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2025-2030 (USD MILLION)
TABLE 283. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2024 (USD MILLION)
TABLE 284. MEXICO BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biopharmaceutical CMO & CRO market report include:
  • IQVIA Services Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group AG
  • Syneos Health, Inc.
  • Charles River Laboratories International, Inc.
  • ICON plc
  • Catalent, Inc.
  • Parexel International Corporation
  • WuXi Biologics Co., Ltd.
  • Samsung Biologics Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 113.74 Billion
Forecasted Market Value ( USD ) by 2030 $ 261.14 Billion
Compound Annual Growth Rate18.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biopharmaceutical CMO and CRO Market Report 2025 - Product Image

Biopharmaceutical CMO and CRO Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Preclinical CRO Market Report by Service, End Use, and Region 2024-2032 - Product Image

Preclinical CRO Market Report by Service, End Use, and Region 2024-2032

  • Report
  • 148 Pages
  • Global
From
Pharmaceutical Analytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), End-use, and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Analytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Service (Bioanalytical Testing, Method Development & Validation), End-use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Global
From
Preclinical CRO Market Opportunities and Strategies to 2033 - Product Image

Preclinical CRO Market Opportunities and Strategies to 2033

  • Report
  • 323 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.